Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.

Phirangkul KerdpanichPornthep ChanthavanichMari Rose De Los ReyesJodor LimDelia YuMa Cecilia AmaZenaida MojaresDaniela CasulaAshwani Kumar AroraMichele Pellegrini

Published in: PLoS neglected tropical diseases (2018)

The data suggest that the 4-site/1-week regimen might be an alternative to current recommendations, with potential benefits in terms of improved cost-efficiency and compliance to vaccination.

Keyphrases

phase iii
placebo controlled
clinical trial
young adults
double blind
open label
phase ii
study protocol
electronic health record
physical activity
big data
clinical practice
human health
machine learning
data analysis
artificial intelligence
deep learning
risk assessment